- Home
- AGAE vs MDAI Comparison
AGAE vs MDAI Comparison
Compare AGAE & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- MDAI
- Stock Information
- Founded
- AGAE 2017
- MDAI 2013
- Country
- AGAE United States
- MDAI United States
- Employees
- AGAE N/A
- MDAI N/A
- Industry
- AGAE Cable & Other Pay Television Services
- MDAI Medical/Dental Instruments
- Sector
- AGAE Telecommunications
- MDAI Health Care
- Exchange
- AGAE Nasdaq
- MDAI Nasdaq
- Market Cap
- AGAE 35.0M
- MDAI 28.3M
- IPO Year
- AGAE N/A
- MDAI N/A
- Fundamental
- Price
- AGAE $0.90
- MDAI $1.96
- Analyst Decision
- AGAE
- MDAI Strong Buy
- Analyst Count
- AGAE 0
- MDAI 3
- Target Price
- AGAE N/A
- MDAI $4.50
- AVG Volume (30 Days)
- AGAE 31.1K
- MDAI 1.6M
- Earning Date
- AGAE 11-14-2024
- MDAI 11-06-2024
- Dividend Yield
- AGAE N/A
- MDAI N/A
- EPS Growth
- AGAE N/A
- MDAI N/A
- EPS
- AGAE N/A
- MDAI N/A
- Revenue
- AGAE $9,256,023.00
- MDAI $27,264,000.00
- Revenue This Year
- AGAE N/A
- MDAI $61.78
- Revenue Next Year
- AGAE N/A
- MDAI N/A
- P/E Ratio
- AGAE N/A
- MDAI N/A
- Revenue Growth
- AGAE 36.15
- MDAI 44.52
- 52 Week Low
- AGAE $0.61
- MDAI $0.82
- 52 Week High
- AGAE $1.57
- MDAI $3.72
- Technical
- Relative Strength Index (RSI)
- AGAE 52.71
- MDAI 44.95
- Support Level
- AGAE $0.89
- MDAI $1.91
- Resistance Level
- AGAE $0.93
- MDAI $2.24
- Average True Range (ATR)
- AGAE 0.07
- MDAI 0.33
- MACD
- AGAE 0.02
- MDAI -0.09
- Stochastic Oscillator
- AGAE 47.23
- MDAI 3.73
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.